IF1 may promote pathological cardiac hypertrophy via cytosolic activation of calcium–calmodulin kinase II to disrupt mitochondrial calcium handling (CaMKII) [34]. The gene discussed is ATP5IF1; the disease is cardiac hypertrophy.